Antenatal exposure to nonsteroidal anti-inflammatory drugs and risk of neonatal hypertension

Keyphrases

• Antenatal Exposure 100%
• Bronchopulmonary Dysplasia 16%
• Calcium Channel Blockers 33%
• Consecutive Days 16%
• Delivery Date 16%
• Drug Exposure 33%
• Gestational Age at Delivery 33%
• Hospitalized Neonates 16%
• Hypertension 66%
• Increased Incidence 16%
• Indomethacin 16%
• Low Gestational Age 16%
• Maternal-neonatal 16%
• Multivariable Logistic Regression 16%
• Neonatal Characteristics 16%
• Neonatal Complications 33%
• Neonatal Hypertension 100%
• Neonatal Intensive Care Unit 16%
• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 100%
• Prenatal Exposure 33%
• Preterm Birth Prevention 16%
• Preterm Infants 16%
• Respiratory Distress Syndrome 16%
• Retrospective Case-Control Design 16%
• Surfactant Administration 16%
• Systolic BP 16%
• Tocolytics 66%
• Umbilical Artery Catheterization 16%
• Uterine Contraction 16%
• Vascular Bed 16%
• Ventilation Rate 16%

Medicine and Dentistry

• Calcium Channel Blocking Agent 33%
• Case-Control Study 16%
• Drug Exposure 33%
• Drug Therapy 16%
• Gestational Age 33%
• Indometacin 16%
• Logistic Regression Analysis 16%
• Lung Dysplasia 16%
• Neonatal Infant 33%
• Neonatal Intensive Care Unit 16%
• Neonate 16%
• Nonsteroid Antiinflammatory Agent 100%
• Premature Labor 16%
• Prenatal Exposure 33%
• Respiratory Distress Syndrome 16%
• Surfactant 16%
• Umbilical Artery Catheterization 16%
• Uterine Contraction 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Calcium Channel Blocker 33%
• Case-Control Study 16%
• Indometacin 16%
• Lung Dysplasia 16%
• Non-Steroidal Anti-Inflammatory Drug 100%
• Premature Labor 16%
• Prenatal Exposure 33%
• Respiratory Distress Syndrome 16%
• Surfactant 16%